European and US reference biologics will be accepted by Switzerland's medicines regulatory for biocomparability exercises, but bridging studies may be necessary • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
